2024 SPEAKERS

Data science executive since 2009. PhD Computer Science 2007. MBA University of Cambridge 2023.

Professor Raghib Ali is the CEO, Chief Investigator and Chief Medical Officer of Our Future Health; a Clinical Epidemiologist at the University of Cambridge; a Consultant in Acute Medicine at the Oxford University Hospitals NHS Trust; and Honorary Consultant with the Office for Health Disparities...

Katie Baca-Motes is the Chief Strategy Officer at CareEvolution, a healthcare technology company at the forefront of digital health innovation.  She is renowned for her global collaborations in research, demonstrating how digital health innovations can revolutionize healthcare through enhanced...

Frederico Braga is a highly skilled and passionate life sciences executive with an impressive track record of managing complex IT solutions that cater to the needs of business users. Currently, he serves as the Head of IT and Digital at Debiopharm, where he leads the company's digital...

Director at large science and technology company, significantly growing the impact of Digital Chemistry accross the business. Strategic leader with decade hands-on experience of developing computer simulations for molecules and materials.

I am currently the Global Head of IT at Teoxane Laboratories in Geneva, where I leverage my expertise in digital transformation and data management within the life sciences sector. My professional journey includes prominent roles at renowned companies such as Takeda and Sanofi, where I specialized...

John brings deep experience building AI/ML-driven computational chemistry, computational biology, and 'omics teams for drug discovery and biomarker development. John is currently the Chief Data Scientist and Information Officer at Monte Rosa Therapeutics.  Previously, he served as Associate...

Calvin holds a PhD in biosciences in bioinformatics from Heidelberg University (Heidelberg, Germany), a Master of Applied Science in Electrical/Biomedical Engineering from Queen's University (Kingston, Canada) and Bachelor of Computer Engineering from McMaster University (Hamilton, Canada) and...

Didier Clénet has extensive experience in R&D at Sanofi with biophysics and bioproduct development, covering both biotherapeutics and vaccines. He is now focusing his work as principal scientist on formulation optimization of vaccines using lab-automation platform and advanced analytics.

Designing and delivering new digital solutions to accelerate research and manufacturing

Dan Crowley is co-founder and CEO of RemedyBio, a single cell technology company focused on patient-derived discovery in cancer and autoimmune disease.  Prior to RemedyBio, Dan co-founded and led Genomics Medicine Ireland (acquired in 2018) and was a Venture Partner with Arch Venture Partners.   ...

Dr. Vivek Das is a Lead Data Scientist at Integrated Omics – AI and Analytics Department in Novo Nordisk A/S in Denmark. His work involves in-silico Biomarker and Target discovery in Chronic Diseases settings via integration of big data e.g. bulk/single-cell multi-omics along with relevant...

Hans Demeyere is a Senior Manager in the Global Healthcare Affairs & Market Access team at Boehringer Ingelheim (BI) Human Pharma. He is responsible for providing market access and pricing expertise to BI's markets and therapeutic areas. In his current role, he focuses on initiatives and...

Robert is a drug and medical device development professional focusing on patient safety, digital transformation and use of AI. He holds MD Diploma from Pécs University, Hungary along with Board Certification of General Surgery and Pharmaceutical Medicine. He has extensive experience in various...

Victor is the VP of Strategy & Operations at Resolution Therapeutics. Victor began his life sciences career as a Venture Fellow at Flagship Pioneering in 2012, after which he founded Desktop Genetics, a genome editing bioinformatics and AI company. Victor led the company through multiple...

Thierry Dorval received a Ph.D. in image analysis and Artificial Intelligence from University Pierre & Marie Curie and then joined the institut Pasteur Korea in 2005 as a group leader specialized in High Content Screening applied to cellular differentiation and toxicity prediction. In 2012 he...

With nearly 20 years of experience in the healthcare and biotechnology sector, Nadjia Drici is a senior global leader who drives business growth and customer success through innovative and transformative IT solutions, and a uniquely-positioned scientific backgroun. As the Global Head of IT for...

Dr. Michel Dumontier is the Distinguished Professor of Data Science at Maastricht University, founder and executive director of the Institute of Data Science, and co-founder of the FAIR (Findable, Accessible, Interoperable and Reusable) data principles. His research explores socio-technological...

check out here https://www.linkedin.com/in/tehmer/

Octavian (Tavi) Filoti is an Associate Director at BMS, leading the AI Enablement Lab. Tavi started out as a Scientist, culminating with a Ph.D. in Nuclear Physics, only that along the way, Data Science sent him on-course with Technology, which started with an M.S. in Computer Science, and...

Anna joined SDSC as a Data Scientist focusing on industry collaborations in July 2019. She completed her PhD in Bioinformatics at the University of Luxembourg, where she analysed large-scale heterogeneous datasets and leveraged multiple disciplines: Statistics, Network Analysis, and Machine...

Ankit Geete has 10 years of experience working in the pharmaceutical industry in different roles. Ankit has a unique skill set combining pharmaceutical science, data, and technology. His aim is to generate business value through data and innovation. His background enables him to demonstrate...

Dr. Torsten Grünewald has a scientific background and worked in the Telecommunications industry working before joining Boehringer Ingelheim. Within Boehringer he held various functions in Business and IT, always dealing with Data, Processes and Business Architecture. In his previous position he...

Andreas Holm Mattsson serves as Chief AI Officer at Evaxion, where he’s been at the forefront in silico-based vaccine target discovery. He has played a key role in developing Evaxion’s innovative AI-immunologyTM platform, a proprietary AI technology for identifying novel vaccine targets for cancer...

Youssef is an Applied Mathematics Engineer with a remarkable international career. Youssef has been at the helm of Connercial, Medical and Government affaits Data Science and AI group, successfully establishing and scaling an AI product-focused organization. Notable among their achievements is the...

Guglielmo is a Biomedical Engineer with an extensive background in Software Engineering and Data Science applied to different contexts, such as Biotech Manufacturing, Healthcare and DevOps, just to mention the latest, and a lifelong learner. In MSD, as part of the Data Science and Advanced...

Rolf Jautelat is heading the R&D Product Owner Hub, part of the R&D Data Science & AI unit of Bayer Pharmaceuticals. There, he is involved in organizing the digital landscape and driving the digital transformation for R&D Pharmaceuticals. Previously, he was ingrained in the...

Science lead passioned about reproduciblity. I have 10 years of experience working in industry, developing advanced data-analytics solutions, progressing the understanding of resistance-evolution modelling and leading a large team and multiple strategic initiatives on digital transformation and...

Hie Lim Kim specializes in population genomics, which study genetic variations within or between populations to understand their demographic history. She received her Ph.D. training in population genetics from the Graduate University for Advanced Studies in Japan and continued her postdoctoral...

Robert Kitchen, Ph.D. leads a global computational biology team at Novo Nordisk.  The department focuses on applying systems biology and machine learning to identify drug target candidates from high-throughput in-vitro functional screening and unveiling endotypes of cardiometabolic diseases.  Prior ...

As Head of Biomarker & Data Insights at Bayer AG (Berlin, Germany) Karl leads a team of data scientists / statisticians. With a background in omics data science and precision medicine, his team’s major objective is to advance drug development by enabling holistic understanding of complex...

Partha Krishnan started his career as a bench scientist and transitioned to career in occupational health and safety spanning over a decade, where he has held positions of increasing responsibilities at UCLA, Yale and Harvard before his current position at Sanofi where he is the Biosafety and...

Zoran Krunic, Senior Manager of Data Science, Amgen   Since joining Amgen R&D in 2018, Zoran Krunic has been at the forefront of applying Machine Learning to enhance patient outcomes and streamline clinical trial enrollment processes, utilizing comprehensive Electronic Health Records and...

Alexander Krupp is responsible for the transformation of Bayer’s clinical development business towards innovative trial designs and to ensure seamless interactions with the ecosystem of discovery partners. He is passionate about delivering digital strategy in the LifeSciences...

Shawn is passionate about harnessing the power of data engineering, strategy, and analytics in order to help businesses uncover new opportunities. As an innovative technologist with over 15 years of experience, Shawn removes technology as a barrier and broadens the art of the possible for business...

Vincent Lepreux is the Investment Principal at Debiopharm Innovation Fund, focusing on early-stage digital health and techbio startups. He has over four years of experience in this role, emphasizing investments in digital health to improve patient care pathways and transform pharmaceutical...

Jobst Loeffler currently holds the role of an IT Product Owner in Pharma Research and Development at Bayer. His main focus is on preclinical and clinical data platforms, Cloud technology and data science. Originally trained as Physicist, Jobst completed a PhD in Computer Science and holds an MBA...

Patrick Loerch joined Gilead in 2020 as the Senior Vice President of Clinical Data Science where he is responsible for bringing together the data science and technology functions across Development to build an industry-leading, integrated evidence and insights generation function spanning...

Dr. Amrik Mahal currently serves as the Global Head of Information Technology for Research at AstraZeneca. In this capacity, he is responsible for shaping the IT strategy, collaborating with R&D senior leaders, and overseeing the delivery of all IT projects, services, and capabilities. He is...

Nour is a Programme Manager for the multimodal initiative at Genomics England, currently leading on the acquisition and ingestion of healthcare data allowing for linking of diverse modalities to support the platform's development in enabling users to conduct analysis using ML/AI to unlock...

With over 15 years of experience in reimagining the future of work across different industries (specialty chemicals, power generation, oil and gas, pharma), I've spent the last 6 years at Roche ideating, developing and implementing blueprints for the future state of Pharma.   This includes...

Lars is CEO of Engimmune Therapeutics since April 2023. Before that he was CTO and CEO at Nordic Nanovector, a biotech company developing novel radio-immunoconjugates for treating cancers. Previously, Lars was VP and Strategic Product Lead at Bayer. Before that he held several leadership roles at...

Michael Oellerich, MD, HonMD, FAACC, FAMM, FFPath (RCPI), FRCPath, is a chemical pathologist andcurrently a Distinguished Research Professor at the Department of Clinical Pharmacology, Medical Faculty(UMG) of the George-August University, Göttingen, Germany. From 2012 to 2017 he had an...

Dr. Paoletti Samantha is enabling collaborative innovation in the Life Sciences and the Healthcare domains. Working as Head of Research and Business Development for Life Science Technologies at CSEM, she is responsible for identifying market needs and for the strategic planning of internal...

Stephen D Pickett has degree in Chemistry from Keble College, Oxford and a PhD from the Royal Institution of Great Britain/Imperial College, where he studied under Professor Sir John Meurig Thomas on the adsorption and diffusion of small molecules in zeolites using Monte Carlo and Molecular...

Dr. Philippe Pinton is Senior Vice-President, Global Head of Clinical And Translational Sciences (CATS) at Ferring Pharmaceuticals. The CATS structure is a global integrated matrix from Discovery and Research to late-stage Clinical Development that focuses on severe unmet medical needs to deliver...

Seasoned business technology leader with rich experience in incubating and scaling strategic initiatives with AI and Automation. Holistic leadership experience in the transformative technology value chain, portfolio management, and strategic ROI realization from innovations.

More recently, I joined Roche Basel as Market Solutions Lead for R&D, Procurement. Here, I developed a Global team that focuses on co-creating, delivering, implementing and enhancing R&D solutions for complex business challenges and opportunities. Some of these challenges revolve around the ...

Jacob Reimers has more than a decade of experience leading technology projects in the digital diagnostics space Currently he works on large scale analytics platforms for diagnostics research.

Dr. Alessandro Riccombeni is the CEO and founder of Axia Medicine, a patient-centric Personalised Healthcare company. Alessandro has more than 16 years of international experience in business strategy, product development and research. Before creating Axia Medicine, Alessandro led the Precision...

Michael Rossi, PhD, FACMG is VP of Translational Science & Multi-Modal Real World Evidence Solutions at ConcertAI. Prior to ConcertAI, Mike was the Division Head of Molecular Oncology for Solid Tumors at Sema4 and Associate Professor in the Department of Genetics & Genomic Sciences at the...

Mike Sacco, presently serving as the Corporate Vice President of Clinical Reporting at Novo Nordisk, boasts over two decades of invaluable experience within the pharmaceutical sector. His career spans diverse areas such as Pharmacovigilance, Quality Assurance, and Clinical Drug...

•He is the Head of AI for healthcare and health economics at Bayer Pharmaceutical. He is also the founder of AI-HUT in Dubai, UAE. With a background in AI and deep learning engineering, Ghaith actively mentors in the AI 4 Medicine Specialization program at deaplearning.ai. He worked as Data...

Arndt A Schmitz, PhD MBA, is in the pharmaceutical industry for more than 20 years. He is spearheading digital transformation as Medical Software Product Lead. Prior that, he was a biomarker expert in clinical development and lead international academic-clinical collaborations. This was based on ...

M.D. University of Copenhagen.   > 30 yrs experience from healthcare, pharmaceutical industry, biotech, CRO and regulatory authorities / governmental administration. Since 2021 Senior Vice President Data Science at Novo Nordisk leading app 1000 data scientists across various domains and...

I am an IT leader and transformer with over 30 years of experience across three life sciences industries: agriculture, pharmaceuticals, and environment. I have held leadership positions in IT and R&D. I have a proven track record in leading international teams and delivering business value...

Louise is Head of Content Digitalisation at Novo Nordisk. In her current role at Novo Nordisk, Louise plays a pivotal role in advancing the way clinical and regulatory documents are managed and processed. Leading the digital transformation effort, she heads the development of innovative...

Etzard leads the global Information / Knowledge Management effort in Pharma Manufacturing for F. Hoffmann-La Roche, with a focus on processes and tools for effective knowledge utilisation. All capabilities are driven by AI (NLP/LLM) methods to improve quality of insight and efficiency of knowledge...

Jędrzej leads a team of machine learning engineers helping clients and partners reach better and faster methods of processing their data. The team specializes in applications of deep learning both in computer vision and on omics data. Most of the work has been commercial, but many of the models and ...

Becky was appointed as the Pistoia Alliance’s first female President in June 2022. She is a long-time supporter of pre-competitive collaboration in life sciences and healthcare R&D and the critical role it plays in advancing science and is passionate about diversity in STEM. Becky is...

Mieke Van Hemelrijck leads the Translational Oncology and Urology Research (TOUR) Team in the School of Cancer & Pharmaceutical Sciences at King's. She became a Reader (Associate Professor) in Cancer Epidemiology in September 2018, and became a Professor in late 2020. She joined the Group...

Dr von Scholten is a medical doctor from the University of Copenhagen, Denmark. In addition, Dr von Scholten was in 2018 awarded the highest achievable academic degree as Doctor of Medical Science (DMSc). This degree was based on extensive clinical research in the cross-field of data science and...

Sam is recognized as an influencer in the field of pharmaceutical data science and analytics.  Her career spans 3 decades, bringing depth and perspective of not only how we manage, analyse and share data but why we do it.  She is passionate about enabling the data to tell its story to support great ...

John Wise John is a consultant with the non-profits PRISME Forum and the Pistoia Alliance with responsibilities that include development and member relations. He specialises in the coordination of pre-competitive collaborations in life science R&D IT and healthcare. Previously, John has held...

I am an experienced Informatics and Information Management professional, with an established track record of delivery in the BioPharma industry. This includes Research, Biopharmaceutical and Clinical Informatics as well as Knowledge and Information Management for the whole of R&D and supporting ...